Back to top

View the PFP Archive

Stocks closed mostly higher yesterday with moderate gains.
Kevin Matras   
Profit from the Pros
By Kevin Matras
Executive Vice President
Zacks Investment Research
  

Rising Earnings And Falling Yields Lifted Stocks Yesterday

Stocks closed mostly higher yesterday with moderate gains.

While rising Treasury yields the other day were cited as being partly responsible for Tuesday's decline in equities, yesterday's falling yields, in turn, helped lift stocks on Wednesday.

News that the Treasury Department would increase buybacks on long-term debt, improved liquidity and thus reduced yields -- an important development as the U.S. debt is now at $40 trillion and requires a huge amount of Treasuries to finance it.

The move helped reverse a multi-day selloff in bonds.

In other news, reports that Moderna's personalized mRNA cancer therapy (developed with Merck) cut melanoma recurrence in a late-stage trial sent Moderna shares up 177%, and Merck up 12.6%. That served to lift healthcare stocks, especially biotech and pharma names. Healthcare is roughly 9% of the S&P and provided the biggest sector-level boost yesterday.

Positive earnings news from retail yesterday also buoyed stocks.

Before the open, Target posted a positive EPS surprise of 6.96%, and a positive sales surprise of 1.57%. That translated to a quarterly EPS growth rate of 20% vs. this time last year, and a sales growth of 5.28%. They were up 4.28% yesterday.

Estee Lauder also crushed with a positive EPS surprise of 21.88%, and a positive sales surprise of 2.15%. That equated to a quarterly EPS growth rate of 333%, and a sales growth of 6.45%. They soared by 16.30% yesterday.

Today we'll hear from another 103 companies on deck to report, including Walmart, Deer and NetEase to name a few.

On the economic report front yesterday, MBA Mortgage Applications slipped -0.4% w/w, with Purchases off -2.0%, and Refi's up 1.5%.

And the Atlanta Fed Business Inflation Expectations remained unchanged at 2.2% y/y, in line with last month's pace.

We also got the FOMC Minutes from last month's Fed meeting. But there were no real surprises. Three members pushed for rate hikes vs. the nine who voted to keep rates unchanged. However, sentiment was a bit more hawkish in that "several participants favored an increase," even though only 3 dissented. Nonetheless, expectations were a bit hawkish going into it, so not really new.

The Minutes also noted that members were wary that the Middle East turmoil could prolong supply chain disruptions.

And the Minutes also revealed that Fed Chair Kevin Warsh floated a structural change for fewer meetings per year (6) vs. the current 8.

All in all, nothing really new. And the market took it all in stride.

Today we'll get Weekly Jobless Claims, the Philadelphia Fed Manufacturing Index, and the Leading Indicators Report.

And, of course, the market will be listening for any new news out of the Middle East.

See you tomorrow,

, Zacks Investment Research

Sponsor

The Best $1 Investment You Can Make

This unique Zacks Ultimate arrangement grants you 30-day access to all our private portfolios–for only $1 without a cent of additional obligation.

Our private portfolios have closed 139 double and triple-digit gains so far this year. While not all our picks are winners, members have seen recent gains of +281.4%, +415.1%, +653.6%, and even +2,027.7%.�

Start Zacks Ultimate Access Now »

Most Popular Articles from Zacks.com

Image: Bigstock

Moderna or Merck: Which Soaring Cancer Vaccine Stock Is the Better Buy?

MRNA and MRK are soaring Wednesday after the companies reported a potentially historic breakthrough for their personalized mRNA cancer vaccine. Read More »

Image: Bigstock

Tech & Energy Fuel S&P 500 Growth Engine

Even when excluding hefty contributions from Micron and Alphabet, the overall Q2 earnings picture remained rock-solid. Read More »

Image: Bigstock

Insider Watch: 3 CEOs Betting Millions on Their Own Stocks

INTC, CSGP and PFE have seen recent insider activity from their CEOs. Read More »

Image: Bigstock

NVIDIA vs. Broadcom: The AI Stock You Should Buy Right Now

Recently registering strong growth and profitability, both NVIDIA (NVDA) and Broadcom (AVGO) have gained from the accelerating AI boom. Read More »

Image: Bigstock

Snowflake vs. DELL: Which AI Infrastructure Stock Is the Better Buy?

While both SNOW and DELL stand to benefit from the AI infrastructure boom, DELL's stronger earnings momentum, diversified growth drivers and consistent performance suggest it may offer greater upside potential in the near term. Read More »

Sponsor

Increase Investment Returns with Free Zacks' Portfolio Tracker

Catch breaking news on your stocks and funds at a glance, including timely recommendation changes ... Zacks Ranks ... Industry Ranks ... earnings announcements ... earnings estimate revisions ... and more. And now you can screen for new stocks to improve portfolio performance.

Click for Free Tracker & Screener »

Image: Bigstock

Bull of the Day: Ceva (CEVA)

Brains of the semis that deliver connectivity, sensing, and edge inference is on a "royal" path to profits. Read More »

New Zacks Strong Buys for August 20th

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today. Read More »

 

Download our app for convenient on-the-go access to even more—daily and weekly newsletters published by Zacks experts, proprietary research and tools, and Portfolio Tracker on Zacks.com.

Download our Zacks App for Apple iOS
Download our Zacks App for Android

Visit Success Stories to hear how Zacks research, tools and portfolios help our members outperform the market.